GATA3 and eosinophilic esophagitis: When assessing all EoE risk loci identified in this study, we observed overlap with GATA3 ChIP-seq peaks at 16 risk variants spanning independent risk loci; however, enriched GATA3 ChIP-seq overlap was not robust to multiple testing correction (p-adjusted > 0.05).